Zacks Research Brokers Boost Earnings Estimates for CLB

Core Laboratories Inc. (NYSE:CLB) – Zacks Research upped their Q1 2027 earnings estimates for Core Laboratories in a report released on Thursday, March 26th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings per share of $0.20 for the quarter, up from their prior estimate of $0.19. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2027 earnings at $0.32 EPS.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The firm had revenue of $138.26 million for the quarter, compared to analyst estimates of $130.40 million. During the same period in the previous year, the company earned $0.22 earnings per share. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS.

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Core Laboratories presently has an average rating of “Hold” and an average price target of $12.50.

Core Laboratories Trading Up 7.2%

Core Laboratories stock opened at $17.61 on Friday. The company has a quick ratio of 1.57, a current ratio of 2.02 and a debt-to-equity ratio of 0.41. Core Laboratories has a 52 week low of $9.72 and a 52 week high of $20.36. The company has a market capitalization of $810.85 million, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 14.33 and a beta of 1.10. The stock has a 50-day moving average price of $17.81 and a 200 day moving average price of $15.94.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were paid a $0.01 dividend. The ex-dividend date was Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Core Laboratories’s dividend payout ratio is presently 5.97%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. CWM LLC boosted its position in Core Laboratories by 36.1% in the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares in the last quarter. Platinum Investment Management Ltd. increased its holdings in shares of Core Laboratories by 3.9% during the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock valued at $294,000 after purchasing an additional 889 shares in the last quarter. Illinois Municipal Retirement Fund lifted its stake in shares of Core Laboratories by 4.0% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 23,366 shares of the oil and gas company’s stock valued at $289,000 after purchasing an additional 898 shares during the period. Advisors Capital Management LLC lifted its stake in shares of Core Laboratories by 0.3% in the 3rd quarter. Advisors Capital Management LLC now owns 275,975 shares of the oil and gas company’s stock valued at $3,411,000 after purchasing an additional 912 shares during the period. Finally, Fox Run Management L.L.C. boosted its holdings in Core Laboratories by 5.9% during the third quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock worth $229,000 after buying an additional 1,038 shares in the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.